In the latest achievement for QuantWave's forecasting platform, the stock of PFIZER INC. successfully reached the price target as predicted....
Pfizer Inc. stock recently hit the price target forecast by QuantWave, resulting in a profit of 6.03%. The forecast signal was generated on June 18, 2025, with a price of $23....
On June 20, 2025, QuantWave forecasted a long signal for PFIZER INC., with a price of 23.97 $. The target price of 25.32 $ was reached on July 2, 2025, resulting in a profit of 5.63%....
On May 5, 2025, QuantWave, the automated forecasting platform, issued a long signal for PFIZER INC. (PFE) when the stock was trading at $23.42. Fast forward to July 2, 2025, PFIZER INC....
On May 2, 2025, QuantWave, the automated forecasting platform, issued a long signal for PFIZER INC. stock when it was trading at 23.75 $....
On May 28, 2025, QuantWave, the automated forecasting platform, issued a long signal for PFIZER INC.'s stock when it was priced at 23.18 $....
PFIZER INC. has successfully reached the price target forecast set by QuantWave, signaling a profitable long position. The forecast signal was issued on 2025-05-21 when the stock was at 23.04 $....
On May 22, 2025, QuantWave issued a forecast signal for PFIZER INC. stock, predicting a long position at a price of $23.04. The target was reached on June 10, 2025, with the stock price hitting $24....
Pfizer Inc. announced a new partnership with Acepodia to develop cutting-edge cancer treatments....
PFIZER INC. has successfully achieved the price target forecast set by QuantWave, with a profit of 7.0%. The forecast signal was issued on April 2, 2025, at a price of 24.24 $....
Regeneron Pharmaceuticals Inc. (REGN) recently held its Q4 2024 earnings call, highlighting strong revenue growth and positive developments in its portfolio....
Regeneron Pharmaceuticals Inc., a leading biotechnology company, announced its impressive financial results for the fourth quarter of 2024....
AbbVie Inc., a renowned pharmaceutical company, is gearing up to make a significant appearance at Citis 2024 Global Healthcare Conference....
Eli Lilly and Company, a global pharmaceutical corporation, has recently confirmed their participation in the upcoming J.P. Morgan Healthcare Conference....
Regeneron Pharmaceuticals, Inc. recently made headlines with the approval of Dupixent by the US FDA, in collaboration with Sanofi....